Bret Fisher, MD
Ophthalmology · Homewood, ALNPI 1174559660
Payments from drug & device makers
Across 461 payments — averaging $1781.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ziemer USA$413K
- Alcon Research LLC$307K
- Alcon$86K
- Ocular Therapeutix, Inc.$10K
- Bausch & Lomb Americas Inc.$3K
- Sun Pharmaceutical Industries Inc.$793
- plus $3K from 14 others
Across 8 payments — averaging $619.13 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sun Pharmaceutical Industries Inc.$5K
What the payments were for
- Consulting fees$486,85589%
- Speaking & faculty fees$39,1947%
- Travel & lodging$11,5992%
- Food & beverage$7,6901%
- Other$1400%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ziemer USA | 15 | $412,560 |
| Alcon Research LLC | 209 | $307,490 |
| Alcon | 139 | $85,600 |
| Ocular Therapeutix, Inc. | 32 | $9,565 |
| Bausch & Lomb Americas Inc. | 4 | $2,528 |
| Sun Pharmaceutical Industries Inc. | 4 | $793 |
| Johnson & Johnson Surgical Vision, Inc. | 15 | $512 |
| Tearlab Corp | 1 | $500 |
| NEW World Medical,inc. | 7 | $376 |
| Glaukos Corporation | 10 | $342 |
| Carl Zeiss Meditec USA, Inc. | 4 | $222 |
| AbbVie | 8 | $185 |
| Biotissue Holdings Inc. | 3 | $142 |
| Harrow Eye, LLC | 1 | $125 |
| Rxsight Inc | 1 | $61 |
| Tarsus Pharmaceuticals, Inc. | 3 | $56 |
| Sight Sciences, Inc. | 2 | $35 |
| Amgen | 1 | $19 |
| Dompe US, Inc. | 1 | $18 |
| Novartis | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FEMTO LDV$480,000
- FEMTOLDV$292,339
- Z8$60,140
- Z6, Z8$60,000
- Clareon$44,540
- ORA$14,879
- PanOptix$12,482
- DEXTENZA$9,064
- Verion$8,400
- ORA System VerifEye$6,300
- LenSx$5,250
- AcrySof IQ PanOptix UV IOL$4,311
- IC-8 Apthera IOL$2,475
- AcrySof$1,400
- NGENUITY$1,400
- Centurion$1,400
- AcrySof IQ VIVITY$1,362
- ReSTOR$742
- TearLab Osmolarity System$500
- AMO PHACO NEEDLE$278
How this compares
$821,142 in reported general payments places this provider in the 95th percentile of 197 ophthalmology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 324 | $5,253 |
| Prednisolone Acetate | 64 | $3,356 |
| Loteprednol Etabonate | 13 | $2,451 |
| MoxifloxacinMoxifloxacin Hcl | 24 | $1,077 |
| Latanoprost | 24 | $261 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Homewood
- Mark HillHomewood$4K
- Sebastian HeersinkDothan$3.9M
- Caroline WatsonHuntsville$292K
- Ronald GrossFairhope$254K
- Ann Arciniegas-BernalBirmingham$142K
- Harsha SenDothan$140K
- John CoxHuntsville$118K
- Young ChoiVestavia$76K
- Kristin BainsBirmingham$40K
- Price KloessMountain Brk$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.